Introduction
The proliferation and differentiation of germ cells in the developing mammalian gonad determine, in part, the fertility of the future adult. This holds especially true for the female germ line that is believed to differentiate during foetal life. Indeed, the post-natal ovary contains follicle-enclosed oocytes that originate from transient mitotic precursors called oogonia, which are present in the developing ovary. These actively proliferate and initiate meiosis, forming non-renewable oocytes that progress throughout meiotic prophase I and arrest at the dyctiate stage. Much of our knowledge regarding molecular mechanisms governing germ cell differentiation comes from studies in rodents and little is known about germ cell development in humans. Because of their delicate nature with regard to fertility, understanding the physiological requirements of human foetal germ cells is therefore crucial.
In mice, germ cell sex fate is determined between 11.5 and 13.5 days post-coitum (dpc) shortly after the somatic sex differentiation in the gonad. During this period, both XX and XY germ cells proliferate actively. At 13.5 dpc, germ cells in the ovary initiate meiosis, whereas in the testis, germ cells progressively stop proliferating to enter a quiescence phase at 15.5 dpc. Male meiosis will be initiated later at puberty (Western et al., 2008; Payne, 2013; Spiller and Bowles, 2015) . The question of whether or not germ cells enter meiosis is dictated by external signals that include the balance between production and degradation of retinoic acid (RA) and the existence of at least one secreted meiosis-preventing factor (Bowles et al., 2006; Bowles and Koopman, 2007; Anderson et al., 2008; Guerquin et al., 2010) . In the developing mouse ovary, RA signalling acts on germ cells to promote the expression of stimulated by RA gene 8 (STRA8), which encode a protein required for pre-meiotic DNA replication. In foetal testis, meiotic entry is actively prevented by the male-specific expression of the RA degrading enzyme, CYP26B1. In addition to CYP26B1, fibroblast growth factor 9 (FGF9) has been suggested as a male-specific factor inhibiting meiosis in the embryonic mouse testis. FGF9 acts as an inhibitor of meiosis through the up-regulation of NANOS2 (Barrios et al., 2010; Bowles et al., 2010) . NANOS2 is an RNA-binding protein acting to 'lock in' the male germ cell differentiation program, maintaining germ cells in the G0/G1 phase and repressing STRA8 expression (Suzuki and Saga, 2008) .
In the human foetal gonad, somatic sexual differentiation starts around 6 weeks post-fertilization (wpf) (Pelliniemi et al., 1993; George and Wilson, 1994; Biason-Lauber, 2010) . Germ cells undergo several rounds of mitotic replication (Bendsen et al., 2003 (Bendsen et al., , 2006 O'Shaughnessy et al., 2007) . The first meiotic cells appear between 9 and 11 wpf (Kurilo, 1981; Gondos et al., 1986; Le Bouffant et al., 2010) . In contrast to the rodents, in which the onset of meiosis and germ cell differentiation occurs in a synchronized wave (Menke et al., 2003; Bullejos and Koopman, 2004; Ungewitter and Yao, 2013) , in the human foetal ovary several germ cell populations overlap in space and time. Indeed, some mitotic oogonia were retrieved near early prophase I oocytes at 15 wpf (Kerr et al., 2008) and even next to follicle-enclosed dyctiated oocytes until at least 18-20 wpf (Fulton et al., 2005; Anderson et al., 2007; Childs et al., 2012) . This, has been reinforced by the detection of NANOG in third trimester ovaries (Byskov et al., 2011) or the detection of PLAP and Oct3/4-positive germ cells, which are likely to be oogonia, in the ovarian cortex until 36 wpf, albeit in very low numbers (Stoop et al., 2005) . Additionally, early meiotic stages are still observed at 20-22 wpf (Roig et al., 2004) . Past this stage, the human foetal ovary is believed to contain mostly arrested oocytes, although several reports described oogonia in third trimester ovaries (Kurilo, 1981; Hoyer et al., 2005; Stoop et al., 2005; Byskov et al., 2011) . As in rodent, RA is a key to instruct meiotic entry in in human germ cells albeit with an intriguing and considerable lack of synchronicity (Le Bouffant et al., 2010) . Additional studies also reported that excess of RA in vitro only induces a mild increase in STRA8 expression and meiotic entry in the human foetal ovary (Childs et al., 2011; Jorgensen et al., 2015) , suggesting the existence of specific mechanisms opposing meiosis in the human foetal ovary when compared to the rodent one.
To clarify the extent of germ cells escaping entry into meiosis in the developing human ovary, we hypothesize that this ovary may partially use the 'testicular signalling pathways' described in rodents. We thus undertook an extensive study on 73 human foetal ovaries ranging from 6.4 to 35 wpf. We analysed the expression and localization of numerous oogonial markers and regulators of meiosis, and used an organ culture model to investigate simultaneously the effect of FGF9 and CYP26B1 signalling on the mitotic/meiotic switch in human female germ cells. We demonstrated that these previously considered 'male repressors of meiosis' are active in the human foetal ovary.
Materials and Methods

Collection of human foetal gonads
A total of 79 human foetal gonads (73 ovaries and 6 testes) were included in the present study. Foetal gonads were harvested from material obtained following legally induced abortions (first trimester of pregnancy, 57 ovaries and six testes), or therapeutic terminations (second or third trimesters of pregnancy, 16 ovaries 14.5, 15, 17, 22, 22.5, 23, 3 × 25, 27, 28, 2 × 30, 31, 32, 35 wpf) , from the Department of Obstetrics and Gynaecology at the Antoine Béclère Hospital, Clamart (France). Foetal age was calculated by measuring the length of limbs and feet according to a developed mathematical model (Evtouchenko et al., 1996) and none of the induced abortions were performed for reasons of foetal abnormality. Foetal ovaries from the therapeutic terminations of pregnancies had to display normal histological features before they were included in the study. Our study was approved by the French Biomedicine Agency (authorization number PFS12-002) and all women gave their informed consent. After collection, foetal gonads were stored in RNA lysis buffer (RLT) (Qiagen Courtaboeuf, France) for gene expression profiling, prepared for organ culture or fixed in Bouin's fluid, or 10% neutral formalin (Formaldehyde 1/10 in distilled water), for histological observations.
Collection of foetal murine gonads
All animal studies were conducted in accordance with the French Ministry of Agriculture guidelines for the care and use of laboratory animals. Pregnant NMRI (Naval Maritime Research Institute) mice were used to harvest foetal gonads at 12.5 days post-conception (dpc). Briefly, males and females were caged together overnight, and the presence of vaginal plug was examined the following morning. Pregnant females were sacrificed by cervical dislocation and their foetuses removed from the uterine horns.
Real-time quantitative PCR
In order to measure the expression of multiple genes during human gonadal development, total RNA from foetal ovaries and testes was extracted using the RNeasy Mini Kit (Qiagen Courtaboeuf, France), followed by a reverse transcription and whole transcriptome amplification (Quantitect Whole Transcriptome cDNA Amplification, Qiagen, Courtaboeuf, France). Twenty different gonads were included for gene expression profiling (17 ovaries and three testes). As previously described (Poulain et al., 2015) , a single ovary was used for 14.5, 17, 22 and 27 wpf, and a single testis for 6 wpf. RNA from similarly aged gonads were pooled leading to an estimated age of 6.7, 7.7, 8.7, 10 and 11.0 wpf for ovaries, and an estimated age of 11 wpf for the testes.
For the gene regulation study, total RNA from ovarian pieces was extracted using the RNeasy mini-kit (Qiagen, Courtaboeuf, France), and reverse transcription performed with the high capacity cDNA reverse transcription kit (Applied Biosystems, Courtaboeuf, France), according to the manufacturer's instructions.
The 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA) and SYBR-green or TaqMan labelling were used for quantitative RT-PCR (RT-qPCR). The comparative ΔΔcycle threshold method was used to determine the relative quantities of mRNA using ACTB (ß-actin) mRNA as reference gene for normalization. Each RNA sample was analysed in triplicate. The results are presented in histograms showing the relative expression of the studied marker with standard deviation. For the gene expression study during gonadal development, results are presented as a percentage of the maximum (i.e. the highest expression is defined as 100%). While for studying the effect of treatment (gene regulation), we reported the level of expression of the studied marker to the level measured in control samples (unexposed, arbitrary fixed at 1). The sequences of oligonucleotides used with SYBR-green detection were designed with Primer Express Software (Supplementary Table SI) .
Histology and immunohistochemistry
A total of 35 human foetal ovaries ranging from 6.4 to 35 wpf (19 from 6.4 to 11 wpf and 16 from 14.5 to 35 wpf) and three foetal testes of 8, 9 and 10 wpf were used for immunostaining studies, as previously described (Poulain et al., 2012) .
The fixed tissues were dehydrated, embedded in paraffin and cut into 5-µm sections. For histology, sections were stained with haematoxylin and eosin. As previously described (Kurilo., 1981) , oogonia were identified as small cells with high nucleocytoplasmic ratio and the presence of prominent nucleoli. Meiotic cells displayed markedly condensed chromatin, forming distinct fine threads with a beaded appearance at the leptotene stage, and a characteristic criss-cross of coiled chromosome threads at the zygotene stage, while oocytes reaching the diplotene stage (naked or enclosed in follicle) had an increased size with the reformation of a single nucleolus (Kurilo., 1981) . The identification of germ cells based on cellular features might allow minor confusions with some germ cells not being taken into account (i.e. mistaken for somatic cells).
Immunohistochemistry (IHC), based on peroxidase activity, was performed using commercially available primary antibodies: anti-SSEA1 (1/ 100, MC480 Cell Signaling, Saint Quentin en Yvelines, France); anti-D240 (1/200, ab77854 Abcam, Paris, France); anti-AP2γ (1/200, sc-12762 Santa Cruz Biotechnology, CA, USA); anti-γH2AX (1/500, Euromedex, Mundolsheim, France); anti-pan-TP63 (1/100, 4A4 Santa Cruz Biotechnology); anti-FOXL2 (1/500, generously given by Pr R. Veitia); anti-Ki-67 (1/100, ASP175 Cell Signalling); anti-FGF9 (1/200, ab71395 Abcam); anti-ALDH1A1 (1/100, ab51028 Abcam); and anti-CYP26B1 (1/ 75, HPA012567 Sigma-Aldrich, Evry, France); anti-DDX4 (VASA) antibody (1/500, Abcam). Briefly, slides were incubated overnight at 4°C with the primary antibody, detected with an adequate secondary antibody conjugated with a peroxidase activity polymer (ImmPRESS reagent kit, Vector Laboratories, Burlingame, CA, USA). For all experiments, peroxidase activity was visualized using 3,3′-diaminobenzidine (DAB, brown), Vector VIP (purple) or HistoGreen as a substrate.
A total of 26 ovaries ranging from 6.4 to 35 wpf were used to evaluate the ratio of positive and negative oogonia for AP2γ. When it was relevant, the proportion of meiotic germ cells not yet enclosed in follicle (ovaries from 11 wpf) and primordial follicles (ovaries from 22 wpf) was also evaluated. Between 700 and 3000 germ cells were counted for each ovary. Additionally, for 10 ovaries ranging from 15 to 35 wpf, we measured the distance between positive or negative oogonia for AP2γ, meiotic cells not yet enclosed in follicle, follicles, and the ovarian surface epithelium (at least 400 measures per ovary). Measurements were performed using Histolab analysis software (Microvision Instruments, Evry, France).
We determined the percentage of positive and negative germ cells for Ki-67 on five first trimester ovaries (6.4, 7.3, 8.0, 8.6, 9.8 wpf) . In late stages, four ovaries (23, 27, 30, 31 wpf) were used to determine the rate of positive cells for Ki-67 among the DDX4-positive oogonia. At least 500 cells (stained or unstained for Ki-67) were counted for each ovary.
Organ culture
All tissues were cultured on Millicell-CM Biopore membranes (pore size 0.4 µm; Millipore, Billerica, MA, USA) in 0.3 ml of Ham's F12/Dulbecco's modified Eagle's medium containing 80 µg/ml gentamicin in an atmosphere of 5% CO 2 /95% air at 37°C. The medium was changed every 48 h.
For meiosis cytological analysis, seven paired ovaries were included (9.6, 3 of 10.0, 10.2, 10.5, 12.8 wpf). Human gonads were cut into small pieces before being placed separately on two to five Millicell membranes as required. Some were systematically used as controls and the others were cultured in the presence of specific inhibitor of CYP26 only (Talarozole 1 µM-R115866, CliniSciences, Nanterre, France) or FGF receptor inhibitor only (1 µM-PD173074, CliniSciences, Nanterre, France) or with both (1 µM of each), or in the presence of the human recombinant protein of FGF9 (1 µM-TP720175, CliniSciences, Nanterre, France) during 14 days. The vehicle (absolute ethanol) was also included in the culture medium of the paired control. The allocation of human ovary pieces into control or experimental conditions was carried out at random for each ovary.
Germ cells were identified after haematoxylin and eosin staining. Each data point represents the mean ± SEM of seven ovaries for control condition and five ovaries for experimental one (Supplementary Table SII) . Additionally, the level of apoptotic germ cells was detected by the use of a double staining for TUNEL (Apop Tag Peroxidase In Situ Apoptosis Detection, Millipore, France) and DDX4 in four ovaries. Three to four sections with an interval of ten sections were analysed per ovary.
We assessed the treatment efficiency by verifying the response of target genes on four ovaries (8.4, 8.7, 10.0, 10.9 wpf) cultured for 24 h in the presence or absence of inhibitors.
Measurement of germ cell proliferation
The percentage of cells in the S-phase was evaluated by IHC. We measured 5-bromo-2′-deoxyuridine (BrdU) incorporation, using a Cell Proliferation Kit (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's recommendations. Overall, 18 pairs of human ovaries from 6.5 to 11.8 wpf were included in this experiment. Ovaries were cut into small pieces before being cultured in presence of BrdU (1/100). Pieces of the same gonads were distributed among different culture conditions and placed separately on Millicell membranes for a period of 3, 6, 12, 24, 48 or 96 h. When the duration of culture was over 24 h, BrdU was added each 24 h. For each culture condition, we used three to seven different ovaries (Supplementary Table SII) .
Mouse foetal ovaries were cultured similarly except that the whole ovary was used for each time point (3, 6, 12, 24 h); ovaries from foetuses from the same pregnant mouse were distributed at different time points. For each culture condition, we used three ovaries from different 12.5 dpc embryos and different pregnant mice (Supplementary Table SII) . After tissue fixation, three to five randomly selected sections with an interval of five sections were mounted, rehydrated, and incubated for 1 h with mouse anti-BrdU antibody and with a peroxidase-linked anti-mouse IgG. Peroxidase activity was then detected by DAB. The BrdU incorporation index was determined by the counting (blinded to experimental group) of at least 500 germ cells (stained or unstained). Each data point represents the mean ± SEM. As staining with BrdU, Ki-67 and DDX4 are poorly compatible, we used double immunostaining for Ki-67/DDX4 and for BrdU/ DDX4 on two consecutive sections and spotted the cells on merged images using the periphery of the section to ensure following cells present on both sections.
Statistical analysis
Each data point represents the mean ± SEM of at least four independent experiments. Data were analysed using Mann-Whitney test. P-values of <0.05 were considered statistically significant.
Results
Oogonia are observed in late foetal human ovaries
We first analysed by qRT-PCR the expression of various markers of the ovarian development at stages ranging from 6.7 up to 27 wpf ( Fig. 1 and Supplementary Fig. S1 ). As expected, from 6 to 10 wpf we observed predominantly the expression of markers associated with pluripotency common to primordial germ cells (PGC) and oogonia such as AP2γ (Fig.1) , NANOG, D240 and NANOS3 (Supplementary Fig.  S1 ). Starting at 11 wpf, we observed markers associated with germ cell differentiation and meiotic prophase I such as STRA8 (Fig. 1) , DAZL and SPO11 ( Supplementary Fig. S1 ). In the late developmental stages after 17 wpf, we retrieved the expression of NOBOX (Fig. 1 ) and the associated elevation of OCT4 and FOXL2 ( Supplementary Fig. S1 ) three markers of dictyate oocytes and surrounding granulosa cells assembled in follicles. NOBOX and meiotic markers were absent in human foetal testes, while all markers associated with pluripotency were retrieved in the early stage testes. Altogether, these results were expected and fit properly with transcriptomic data available (Houmard et al., 2009; Gkountela et al., 2015; Guo et al., 2015) thus validating the protocol used to analyse gene expression.
Of interest, markers associated with PGC and oogonia were still significantly expressed in late developmental ovarian stages (over 20 wpf) after meiosis prophase I and follicle formation had been initiated in numerous cells. These observations prompted us to further analyse the presence of such late undifferentiated germ cells in situ to further characterize their persistence during ovarian development.
A total of 35 human foetal ovaries ranging from 6.5 to 35 wpf were analysed by IHC (Supplementary Fig. S2 ). We first confirmed the presence of early meiotic cells starting at 11-12 wpf and mostly after 14 wpf by the detection of associated marker such as γH2AX a known marker of double-stranded DNA breaks abundant during leptotene The histograms show the relative expression of each marker, normalized to the maximum, using ß-actin as reference gene. For ovaries, a pool of three gonads was used for estimated ages 6.7, 7.6, and 11 weeks post-fertilization (wpf), a pool of two gonads for estimated ages 8.7 and 10 wpf, and one gonad for the age of 14.5, 17, 22 and 27 wpf, respectively. For the testes, one gonad was used for the age of 6 wpf and a pool of two gonads for estimated age 11 wpf. Oogonia marker: AP2γ. Meiotic commitment: STRA8. Follicle marker: NOBOX.
and zygotene stages (Hunter et al., 2001) . Diplotene stages identified by TP63 staining were clearly visible upon 17 wpf and abundantly present in stages over 20 wpf. The first oocytes surrounded by primitive granulosa cells, resulting in primordial follicles were observed over 17 wpf. Histological examination revealed the presence of oogonia at all developmental stages including in third trimester ovaries (n = 10). Starting during the second trimester, some oogonia were observed within the ovarian surface epithelium (OSE) or cortex with many included in nest-like structures. Those observations were confirmed by the detection of markers expressed in oogonia such as SSEA1, D240 and AP2γ (Supplementary Fig. S2 ). We then focused on AP2γ, a known transcription factor playing a key role for PGC specification and maintenance (Weber et al., 2010) . We observed that this marker was expressed in all stages of human ovarian development ( Supplementary Fig. S2 ), and then we quantified the subpopulation of AP2γ-positive oogonia ( Fig. 2A and Supplementary Fig. S3 ). This population decreased progressively during the course of development, but was persistent until very late developmental stages. Between 30 and 35 wpf, germ cells that did not enter meiosis represented about 25% of the total counted germ cells, of which roughly 10% remain stained for AP2γ.
To address the proliferative capacity of these late oogonia, we investigated Ki-67 expression. Among DDX4-positive oogonia, we found that 43.4% expressed Ki-67 suggesting that these cells have maintained a cycling activity (Fig. 2B) while the rest is probably in G1/G0. This activity is comparable to the one observed in first trimester ovary (see later).
Of interest in late ovaries, AP2γ-positive oogonia were mainly found in the outer part of the ovarian cortex, while the more differentiated oocytes were found deeper (Fig. 2C ). As illustrated in Fig. 2D and Supplementary Table SIII, the mean distance of oogonia (stained or unstained for AP2γ) to OSE was shorter than the one of meiotic cells, itself smaller than the one of follicles. The more the cells progressed into meiotic prophase I, the more likely they were to be retrieved in the inner part of the cortex (Fig. 2E and Supplementary Fig. S3 ). Interestingly, little variation for the distance of oogonia and meiotic progressing cells to the OSE as a function of the age was observed, while follicles in the 30-35 wpf ovaries were closer (on average) to the OSE than those of 22-25 wpf ovaries (respectively 220 versus 364 μm).
Altogether, this indicates that female germ cell differentiation is organized both in time and space in a centripetal manner in the human ovary.
Meiotic preventing factors are expressed in the human foetal ovary
As the persistence of germ cells refractory to meiotic entry is usually considered as a testicular feature we wondered whether the same markers inhibiting meiotic initiation in the rodent foetal testis might be present in the human developing ovary. Thus, we investigated the expression (i) of markers known to be associated with male mouse developing germ cells, namely NANOS2 and DNMT3L (Bourc'his and Bestor, 2004); (ii) of somatic factors involved in the prevention of meiosis namely FGF9 and CYP26B1 or expressed predominantly in mouse embryonic testis namely ALDH1A1 (Bowles et al., 2009); and (iii) of PLZF, a known marker of the spermatogonial stem cells (Costoya et al., 2004) (Fig. 3A) . Of note, during the course of this study Aldh1a1 was proposed as a secondary source of RA in mouse ovary (Bowles et al., 2016) . All of these markers were retrieved in the human foetal ovary, albeit DNMT3L levels appeared weak and irregular. It was striking to note that NANOS2 was robustly expressed, as were FGF9 and CYP26B1. As presence of mRNA does not obligatorily reflect synthesis of the corresponding protein, we investigated the presence of CYP26B1, ALDH1A1 and FGF9 by immunostaining in human foetal gonads (Fig. 3B) . Those three proteins were retrieved in the testicular cords in the somatic cells surrounding the germ cells (i.e. Sertoli cells). In the ovary, no specific localization of CYP26B1 could be recognized as the staining was faint and present in both somatic and germ cells regardless of their differentiation state. A clear ALDH1A1 staining was observed in female somatic cells immediately surrounding germ cells. It is of interest that FGF9 staining was often retrieved in the outer cortex and OSE close to mitotic germ cells in late foetal ovary.
Some germ cells display mitotic arrest in the human foetal ovary
In mice, FGF9 and CYP26B1 do not only prevent meiotic entry, but also induce a germ cell mitotic arrest lasting 4-5 days. We thus wondered whether such an event might also occur in the human foetal ovary, as here we retrieved significant levels of both factors. With this in mind, we measured germ cell proliferation in 6.4-11.8 wpf human foetal ovaries using both Ki-67 immunostaining and BrdU incorporation (Fig. 4) . Interestingly, as for later stages, nearly half the germ cells (44.3 ± 1.5%) were unstained for Ki-67, indicating that some may be arrested during their cycle (Fig. 4A) . To further investigate germ cell proliferation, human foetal ovaries were cultured in the continuous presence of BrdU in order to identify proliferating and nonproliferating cells. Even after 96 h, 15% of the human germ cells did not replicate their DNA (85.1 ± 1.9% of stained cells- Fig. 4B -solid line and 4C). Similar experiments performed with mouse foetal ovaries at an equivalent stage indicated that all germ cells proliferate very actively, as barely any remained BrdU-negative after 24 h (Fig. 4B dashed line and 4D). We further analysed these cells in human foetal ovaries and demonstrated that BrdU-negative germ cells were mostly unstained for Ki-67 ( Fig. 4E and Supplementary data, Fig. S4 ). This result indicates that these germ cells were likely arrested in G1/G0. Of interest, some ovaries used for the BrdU-incorporation were about eight wpf (Supplementary Table SII) , so containing exclusively AP2γ-positive cells (oogonia), and these also contained BrdU-negative germ cells after 96 h. Thus, there is no doubt that this mitotic arrest occurs at the oogonial stage without confusion with differentiated germ cells or cells already engaged into meiosis.
Altogether, these results suggest that oogonial proliferation differs between mouse and human, with a possible quiescence in a subpopulation of human germ cells.
Both FGF and CYP26 pathways are active in the human foetal ovary
Finally, the persistence of undifferentiated mitotic germ cells in the human ovary prompted us to investigate the functionality of the two major pathways known to prevent meiotic entry in foetal testis, namely FGF9 and CYP26B1. Using organ culture, we exposed ovaries containing only oogonia to CYP26 or FGFR inhibitors and to human recombinant FGF9 and measured the expression of STRA8 or the presence of meiotic cells (Fig. 5) . In short-term experiments, we first validated the efficiency of various treatments using specific target genes. CYP26A1 and RARβ2 are target genes of RA signalling and are up-regulated in the human foetal ovary following RA-treatment (Le Bouffant et al., 2010) . As expected, those two genes were upregulated following inhibition of CYP26 activity. DUSP6 and SPRY2 are target genes of FGF signalling and were respectively stimulated by human recombinant FGF9 treatment and down-regulated following FGFR inhibition (Fig. 5A) . Having established the efficiency of the treatment, we then measured the expression of STRA8 after 24 h. Surprisingly, neither the CYP26 inhibitor nor FGFR inhibitor alone altered STRA8 expression; only the simultaneous inhibition of both signalling pathways triggered a significant increase in STRA8 expression. This indicates that both pathways are active in the human foetal ovary. In long-term culture (14 days), both CYP26 and FGFR inhibition significantly increased the percentage of meiotic cells, while recombinant FGF9 treatment decreased the percentage of meiotic cells (Fig. 5B) . Notably, no additive effect could be observed in this model. To rule out a possible confusion between apoptotic germ cells and meiotic ones, we further analysed the percentage of apoptotic germ cells in the four culture conditions. Among the DDX4-positive germ cells, <1.5% was apoptotic ( Supplementary Fig. S5 ) negligible in comparison to numerous meiotic cells quantified (up to 30%).
Discussion
Here we identified signalling pathways that are potentially responsible for the persistence of non-meiotic germ cells for several months in the human foetal ovary. Indeed, we observed the expression of CYP26B1, FGF9 and NANOS2 and the occurrence of a mitotic germ cells arrest. Figure 3 Male markers expressed in a human foetal ovary. (A) Using quantitative RT-PCR in human foetal ovaries and testes, we observed the expression of several markers described as male-specific markers in human foetal ovaries. The histograms show the relative expression of each marker, normalized to the maximum, using ß-actin as reference gene for normalization. As in Fig. 1 , the estimated age of ovaries and testes (weeks postfertilization (wpf)) are mentioned for each column. (B) CYP26B1 staining is observed in both ovarian somatic and germ cells, while ALDH1A1 is observed in female somatic cells immediately surrounding germ cells. FGF9 staining was observed close to mitotic germ cells in the outer cortex and ovarian surface epithelium (OSE) of late foetal ovaries. Expression of those proteins was also retrieved in human foetal testes (pictured right) (scale bar, 10 µm).
All these signalling pathways and events are considered as malespecific in mouse developing gonads (i.e. not retrieved in the foetal ovary). Previous reports sustain the hereby-reported expression of CYP26B1 and NANOS2 in the human foetal ovary (Le Bouffant et al., 2010; Childs et al., 2011; Jorgensen et al., 2012) . Using organ culture, we demonstrated that CYP26B1 and FGF9 are likely functional pathways preventing STRA8 induction and meiosis in the human ovary. In the mouse developing testis, FGF signalling and RA-degradation are not only preventing meiotic entry but are also proposed to induce a male fate in the germ cells through the specific up-regulation of NANOS2. This commitment is marked by a mitotic arrest, also termed the 'quiescence phase'. Significantly, we retrieved a peak of NANOS2 expression in the human ovary and observed that some germ cells cease proliferating for a few days (15%). These data suggest that NANOS2 expression and the quiescent phase rather reflect a strategy to avoid meiotic entry than a commitment toward a male fate. Interestingly, rodent gonocytes that resume mitosis after the quiescence phase are the ones that will give rise to long-lasting stem cells in the testis. These gonocytes express some specific markers such as PLZF, which is expressed during human ovarian development (this study and Poulain et al., 2012) . Thus, the present study narrows the differences between the male and female foetal gonads and suggests that the expression of CYP26B1, FGF9 and NANOS2 is not a hallmark of the engagement toward spermatogenesis or a male fate. As a whole, this study questions what is instructing germ cell commitment toward their sexual fate. Previous studies reported the presence of oogonia in second and third trimester ovaries, albeit in very low numbers (Kurilo, 1981; Fulton et al., 2005; Hoyer et al., 2005; Stoop et al., 2005; Anderson et al., 2007; Byskov et al., 2011; Childs et al., 2012) . We now confirm these results by tracing AP2γ, a transcription factor essential for PGC establishment (Weber et al., 2010) , throughout ovarian development. Of particular interest these non-meiotic germ cells display similar localization in the human ovary, widely distributed throughout the tissue during the first trimester and, later, they are mostly restricted to the outer cortical area with a centripetal progressive differentiation and follicle formation. These observations agree with what was previously observed by Anderson and colleagues (2007) that showed that in the second trimester ovaries peripheral germ cells were exclusively marked by the early markers OCT4 or NANOG (outer cortex), whereas more interiorly located germ cells were exclusively marked by the late markers DDX4 or DAZL (inner cortex). A similar distribution of pre-meiotic versus meiotic cells has also been recently reported (Heeren et al., 2016) with DDX4-low OCT4-positive cells in the outer cortex and DDX4-high SYCP3-or γH2AX-positive cells in a zone deeper. As a whole this led us to propose a model (Fig. 6 ) in which germ cell differentiation occurs as a function of their localization. According to this model, we speculated that meiosis-preventing factors would form a gradient starting from the OSE. This hypothesis is sustained by the localization of FGF9 in the outer cortex, but not by that CYP26B1 widely expressed throughout the gonad. Of interest, in human second trimester ovaries, the region of the cortex close to the surface also resembles to a first trimester ovary based on studying the extra cellular matrix (Heeren et al., 2015) . Thus, specific signalling and morphology may be maintained specifically in the outer cortex allowing, the human ovary to conserve together the features of an undifferentiated gonad (e.g. pre-meiotic cells) and female differentiation (e.g. meiotic entry and follicle formation). The simultaneous presence over a long period of germ cells able to divide mitotically while others differentiate and initiate meiosis is considered as a hallmark of the adult testis. Here also, one may argue that the presence long-lasting oogonia with similar properties similar to male germ cell, in the developing human ovary highlights that male and female gametogenesis share more similarities than anticipated. Nonetheless, the presence of these premeiotic cells is another notable difference between murine and human foetal gonads that should question the extrapolation of the mechanisms described in the mouse. Whether the persistence of long-lasting oogonia associated with so called 'male signalling pathways' is a specific feature of the human ovary or common in many large mammals remains to be confirmed. However, this raises the question of what is the requirement for maintaining such cells in an ovary. Notably, women have a fertility that is expected to last for 30 years, while that of a female mouse hardly exceeds 18 months. Such a property may justify the generation of a larger pool of precursors to be available during a longer period. The lasting maintenance of oogonia could allow the progressive establishment of a larger stock of primordial follicles in human and thus a longer fertile life when compared to rodents. Another lead may reside in the requirement of oocytes for maintaining the female identity of the gonad. Indeed, it has been reported that, in rodents, the early loss of tal ovaries ranging from 8.7 to 10.9 weeks post-ferilization (wpf) cultured for 24 h in the absence (control) or in the presence of CYP26 inhibitor and/ or FGF receptor inhibitor or human recombinant FGF9. The histograms show the relative expression of each gene, normalized to the control, using ß-actin as reference gene. Each column represents the mean ± SEM of four independent cultures (*P < 0.05, **P < 0.01 in Mann-Whitney test). (B) Human foetal ovaries ranging 9.9-10.8 wpf were cultured for 14 days in the absence or in the presence of CYP26 inhibitor and/or FGF receptor inhibitor or human recombinant FGF9. At the end of the culture, tissues were fixed, sections were stained with haematoxylin and eosin and the percentage of meiotic germ cells determined. Each column represents the mean ± SEM of seven ovaries for control condition and five ovaries for experimental one (*P < 0.05, **P < 0.01 in Mann-Whitney test). Black arrows point out oogonia and open arrows zygotene oocytes (scale bar, 10 µm).
oocytes triggers the loss of the ovarian fate (Guigon and Magre, 2006) . Thus, one may speculate that a given density of oocytes is needed to maintain the ovarian fate. In this line, it is expected that building bigger ovaries would require a higher number of oocytes. As a conclusion, we report that the developing female and male gonads share common meiotic preventing pathways. These pathways likely induce the persistence of pre-meiotic cells in the human foetal ovary, with features similar to that described in male rodent. Our study questions what defines the early steps of oogenesis or spermatogenesis. Lastly, the divergent development of the mouse and the human female germ lines suggests the existence in the foetal human gonads of additional signalling pathways and meiotic regulators, yet to be identified.
Supplementary data
Supplementary data are available at Human Reproduction online. Figure 6 Proposed model of germ cells differentiation in human foetal ovary. This model is based on the analysis of 16 ovaries ranging from 14.5 to 35 weeks post-fertilization (wpf). Pre-meiotic germ cells are contained mostly in the outer part of the cortex and are exposed to a gradient of FGF9 acting as an inhibitor of meiosis. A part of these cells may be quiescent. Pre-meiotic germ cells leave the outer part of the cortex and develop into meiotic cells toward the inner part of the cortex due to a balance between ALDH1A1/CYP26B1 favourable to retinoic acid (RA) synthesis. Advancing more profoundly in the inner cortex, meiotic cells reach the diplotene stage and develop into maturing follicles toward the centre of the ovary.
